Drug Shortage Report for PDP-ERYTHROMYCIN

Last updated on 2020-09-22 History
Report ID 41037
Drug Identification Number 01912755
Brand name PDP-ERYTHROMYCIN
Common or Proper name pdp-ERYTHROMYCIN 5mg/g OINT OPHT 3.5g
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 5MG
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5g
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-02-23
Actual start date 2018-02-23
Estimated end date 2021-01-15
Actual end date 2020-09-21
Shortage status Resolved
Updated date 2020-09-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v54 2020-09-22 French Compare
v53 2020-09-22 English Compare
v52 2020-05-19 French Compare
v51 2020-05-19 English Compare
v50 2020-03-26 English Compare
v49 2020-03-05 French Compare
v48 2020-03-05 English Compare
v47 2019-12-12 French Compare
v46 2019-12-12 English Compare
v45 2019-12-12 French Compare
v44 2019-12-12 English Compare
v43 2019-11-20 French Compare
v42 2019-11-20 English Compare
v41 2019-10-15 French Compare
v40 2019-10-15 English Compare
v39 2019-09-30 French Compare
v38 2019-09-30 English Compare
v37 2019-07-02 French Compare
v36 2019-07-02 French Compare
v35 2019-07-02 English Compare

Showing 1 to 20 of 54